November 18, 2026 · The American journal of cardiology · DOI: 10.1016/j.amjcard.2026.11.022

Differential Reverse Remodeling but Preserved Clinical Benefit of Sacubitril/Valsartan in Ischemic vs Non‑Ischemic HFrEF.

Listen to this summary

This multicenter retrospective study asked whether left ventricular reverse remodeling (LVRR) after sacubitril/valsartan differs between ischemic and non-ischemic heart failure with reduced ejection fraction, and whether LVRR relates to clinical outcomes. Among 608 patients, both groups improved significantly, but ischemic patients showed smaller LVEF gains and smaller reductions in end-systolic volume index. LVRR was associated with fewer all-cause deaths or HF rehospitalizations regardless of etiology, although it explained only a modest share (about 9%) of the pre-to-post treatment association with outcome.

Erberto Carluccio, Frank L Dini, Michele Correale, Giuseppe Dattilo, Michele Ciccarelli, Daniele Masarone, Stefano Ghio, Valentina Mercurio, Matteo Beltrami, Gaetano Ruocco, Savina Nodari, Francesco Barillà, Giuseppe Ambrosio, Massimo Piepoli, Stefania Paolillo, Gianfranco Sinagra, Alberto Palazzuoli

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play